BioHealth News
OPEN CHALLENGE – BLUE KNIGHT QuickPitch: Activating for the Future
Recent global disease outbreaks have had devastating impacts, triggering a renewed emphasis on preparation for potential known and unknown health threats. By proactively enhancing…
Read More
OpGen Announces Closing of $3.5 Million Public Offering
ROCKVILLE, Md., May 04, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of…
Read More
Biomedical innovation | Deloitte Insights – Unlocking the potential of biomedical innovation: The crucial role the government and partnerships play in accelerating progress
It was an extraordinary achievement. In less than one year, the biomedical ecosystem helped bring to life an mRNA vaccine with the power to…
Read More
CBIC of Virginia Names AMPEL BioSolutions as Innovator-of-Year
Charlottesville, VA - June 2, 2023 - The Charlottesville Business Innovation Council (CBIC) has awarded AMPEL BioSolutions, a leading data science company, with the…
Read More
TEDCO’s The Leading Edge Special Feature at the University of Maryland, College Park, Highlighting MII Awardee
Three entrepreneurial leaders discuss the support available through the MII program COLUMBIA, Md. (June 5, 2023) – TEDCO, Maryland’s economic engine for technology companies,…
Read More
Novavax Announces Agreement with Bill & Melinda Gates Medical Research Institute to Include Matrix-M™ Adjuvant as Potential Component in Vaccine Research
GAITHERSBURG, Md., June 5, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, has signed a three-year agreement…
Read More
BioHealth Capital Region Secures Top 3 Spot in CBRE’s 2023 Life Sciences Talent Report Amidst Booming Industry Growth
The CBRE Life Sciences Research Talent 2023 Report underscores the BioHealth Capital Region's consistent position in the top three hotspots for life sciences talent…
Read More
BISNOW/MCEDC: With Multimillion-Dollar Acquisitions And Developments, Life Sciences To Boom In Montgomery County, Maryland
The life sciences industry is seeing tremendous growth in Maryland, particularly in the D.C. suburb of Montgomery County. With nearly $6B invested in life sciences…
Read More
Precigen Receives FDA Clearance of IND to Initiate Phase 2 Study
Precigen Receives FDA Clearance of IND to Initiate Phase 2 Study of PRGN-2009 Off-the-Shelf AdenoVerse Immunotherapy in Combination with Pembrolizumab to Treat Patients with…
Read More
TEDCO Announces Investment into Pathotrak
COLUMBIA, Md. (May 23, 2023) – TEDCO, Maryland’s economic engine for technology companies, announced a Venture Funds investment of $300,000 into Pathotrak, a biotechnology…
Read More
BioHealth Innovation Welcomes Entrepreneur-in-Residence Claire Leurent, Ph.D. MBA at NIH’s SEED Program
Entrepreneurs-in-Residence (EIR) Team Continues Growth With National Institutes of Health (NIH) ROCKVILLE, MARYLAND, May 30, 2023 – BioHealth Innovation Inc. (BHI) proudly welcomes Claire Leurent,…
Read More
Technical.ly: Meet the Maryland innovators behind the state’s best 2023 inventions
What do you get when you combine a networking happy hour for STEM researchers, an engaging expert panel discussion and a host of exciting…
Read More
Emergent BioSolutions Announces the Execution of Contract Option to Deliver ACAM2000 into the Strategic National Stockpile
On May 26, 2023, Emergent BioSolutions Inc. (including its wholly-owned subsidiaries, “Emergent”), through its wholly-owned subsidiary, Emergent Product Development Gaithersburg Inc., received a contract…
Read More
ABL awarded seven-year NIH contract for continued support in HIV prevention products
Rockville, MD, United States, May 23, 2023 – Advanced BioScience Laboratories (ABL), a global Contract Development and Manufacturing Organization (CDMO) for biotherapies,oncolytics and viral…
Read More
Hememics Biotechnologies, Inc. Announces Successful Close in $2 Million Seed 2 Financing from TEDCO and Qualified Investors to Accelerate Growth
GAITHERSBURG, Md., May 25, 2023 /PRNewswire/ -- Hememics Biotechnologies, Inc., developer of first-in-class, handheld, multiplexed biosensor platform that can test antibodies, antigens and molecular targets simultaneously, announced…
Read More